Search Results - "Luy, P"

531 MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results by Migliorini, D, Vernet, R, Belkouch, M.C, Luy, P, Blaser, S, Ancrenaz, V, Blazek, N, Grandjean, N, Wasem, J, Janin, B, Harboe-Schmidt, P, Grogg, J, Bouche, N, Mach, N

Get full text

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy by Schwenter, F, Zarei, S, Luy, P, Padrun, V, Bouche, N, Lee, J S, Mulligan, R C, Morel, P, Mach, N

“…Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjuvant in autologous cell-based anti-tumor immunotherapy has recently been approved for…”
Get full text

A Scoping Review to Contribute to Knowledge About Culturally Adapting Interventions for Latino Family Caregivers of Persons Living With Dementia by Neidre, Daria B, Delgado, Roxana E, Peacock, Kimberly S, Luy, Luis P, White, Carole L

“…Few interventions have focused on Latino family caregivers to persons with dementia, addressing their unique needs. This review aimed to identify best…”
Get full text

MVX-ONCO-1 phase 1 final results of the first personalized cell-based immunotherapy using cell encapsulation technology by Mach, N., Vernet, R., Belkouch, M.-C., Luy, P., Ancrenaz, V., Teta, P., Blazek, N., Grandjean, N., Wasem, J., Grogg, J., Perez, T., Migliorini, D.

Get full text

Cell-based immunotherapy combining encapsulation cell technology and irradiated autologous tumor cells: A novel technology platform that is both safe and feasible. Results from first in man trial by Mach, N., Migliorini, D., Vernet, R., Belkouch, M.-C., Luy, P., Ancrenaz, V., Py, C., Grogg, J., Harboe-Schmidt, P., Bouche, N.

Get full text